UBS Group’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.79M | Buy |
|
|||||
|
2025
Q1 | $3.53M | Buy |
|
|||||
|
2024
Q4 | $263K | Sell |
|
|||||
|
2024
Q3 | $523K | Buy |
|
|||||
|
2024
Q2 | $490K | Sell |
|
|||||
|
2024
Q1 | $1.56M | Buy |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $201K | Buy |
|
|||||
|
2023
Q2 | $188K | Buy |
|
|||||
|
2023
Q1 | $165K | Sell |
|
|||||
|
2022
Q4 | $184K | Buy |
|
|||||
|
2022
Q3 | $123K | Buy |
|
|||||
|
2022
Q2 | $76K | Buy |
|
|||||
|
2022
Q1 | $38K | Sell |
|
|||||
|
2021
Q4 | $56K | Buy |
|
|||||
|
2021
Q3 | $16K | Buy |
|
|||||
|
2021
Q2 | $19K | Buy |
|
|||||
|
2021
Q1 | $18K | Sell |
|
|||||
|
2020
Q4 | $27K | Sell |
|
|||||
|
2020
Q3 | $22K | Sell |
|
|||||
|
2020
Q2 | $29K | Buy |
|
|||||
|
2020
Q1 | $7K | Sell |
|
|||||
|
2019
Q4 | $23K | Buy |
|
|||||
|
2019
Q3 | $11K | Sell |
|
|||||
|
2019
Q2 | $51K | Buy |
|
|||||
|
2019
Q1 | $30K | Buy |
|
|||||
|
2018
Q4 | $1K | Sell |
|
|||||
|
2018
Q3 | $11K | Sell |
|
|||||
|
2018
Q2 | $8K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $8K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $5K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $8K | Sell |
|
|||||
|
2015
Q4 | $21K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $12K | Buy |
|
|||||
|
2015
Q1 | $6K | Sell |
|
|||||
|
2014
Q4 | $7K | Buy |
|